BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 822586)

  • 1. Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d.
    Freedman J; Mollison PL
    Vox Sang; 1976 Oct; 31(4):241-57. PubMed ID: 822586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a C4 Subcomponent on C3d-coated erythrocytes.
    Michael JM; Moore JA; Chaplin H
    Transfusion; 1976; 16(5):408-16. PubMed ID: 982532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera.
    Garratty G; Petz LD
    Transfusion; 1976; 16(4):297-306. PubMed ID: 951725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the antiglobulin tests. II. C4 components on erythrocytes.
    Stratton F; Rawlinson VI
    Vox Sang; 1976; 31(1 SUPPL):44-54. PubMed ID: 1007151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations on the preparation of antiglobulin reagents reacting with c3d and c4d on red cells.
    Freedman J; Chaplin H; Mollison PL
    Vox Sang; 1977 Jul; 33(1):21-8. PubMed ID: 407724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
    Freedman J; Massey A
    J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement components detected on normal red blood cells taken into EDTA and CPD.
    Freedman J; Massey A
    Vox Sang; 1979; 37(1):1-8. PubMed ID: 115154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia.
    Anwar AR; Kay AB
    J Immunol; 1977 Sep; 119(3):976-82. PubMed ID: 330760
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo instability of red-blood-cell-bound C3d and C4d.
    Chaplin H; Coleman ME; Monroe MC
    Blood; 1983 Nov; 62(5):965-71. PubMed ID: 6605168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
    Giles CM; Davies KA; Walport MJ
    Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and activation of C4 and C3 on the red cell surface by non-complement enzymes.
    Kirschfink M; Borsos T
    Mol Immunol; 1988 May; 25(5):505-12. PubMed ID: 3412332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential coating of human red blood cells with C4 or C3 in a low ionic strength medium.
    Heier HE; Kornstad L; Nordhagen R
    Vox Sang; 1981; 41(4):249-54. PubMed ID: 6801858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.
    Baldwin WM; Samaniego-Picota M; Kasper EK; Clark AM; Czader M; Rohde C; Zachary AA; Sanfilippo F; Hruban RH
    Transplantation; 1999 Sep; 68(6):894-900. PubMed ID: 10515392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
    Petersen NE; Teisner B; Folkersen J; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsin.
    Freedman J; Chaplin H; Johnson CA; Hughes-Jones NC
    Vox Sang; 1977 Oct; 33(4):212-20. PubMed ID: 70885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid method for the production of erythrocytes in the state "EC4" and "EC43".
    Jenkins DE; Moore WH; Luthringer DG; Johnson RM
    Transfusion; 1975; 15(5):402-7. PubMed ID: 812218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection.
    Nordhagen R; Heier Larsen AM; Beckers D
    Vox Sang; 1979; 37(3):170-8. PubMed ID: 91269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.